Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Warning Letter
  6. /
  7. Applied Therapeutics, Inc.
WARNING LETTER
•Applied Therapeutics, Inc.•May 3, 2024

Applied Therapeutics, Inc. – FDA Warning Letter, May 3, 2024

Record Details

On November 27, 2024, the FDA issued a Warning Letter to Applied Therapeutics, Inc. following an inspection from April 29 to May 3, 2024, concerning their role as sponsor of clinical investigation Protocol (b)(4). The inspection, part of the Bioresearch Monitoring Program, identified significant violations of the Federal Food, Drug and Cosmetic Act and 21 CFR 312.

The first violation cited was the failure to permit FDA access to and copy and verify records [21 CFR 312.58]. Specifically, a third-party vendor deleted electronic data, including audit trails, for critical eCOAs from Pearson’s Q-global® for all 47 subjects in Protocol (b)(4) on March 27, 2024, preventing FDA verification. While Applied Therapeutics implemented corrective actions like data backups and restricting vendor deletion capabilities, the FDA deemed the response inadequate due to insufficient detail and continued inability to verify the deleted electronic data.

The second violation was the failure to provide FDA with relevant safety and effectiveness data [21 CFR 314.50(d)(5)(iv)]. Applied Therapeutics failed to report dosing errors for the investigational drug (b)(4), where a mislabeled formulation led to subjects receiving 80% of the required dose between March and June 2021. This information, relevant to drug safety and effectiveness

Company
Applied Therapeutics, Inc.
Inspection date
May 3, 2024
Product type
Drugs
Office
Center for Drug Evaluation and Research
Person
  • David C. Burrow (Director )
View Company Profile

ID · 937af47d-7abf-464d-a9e8-32dac945e1c2

Violation Codes3
21 CFR 31221 CFR 312.5821 CFR 314.50(d)(5)(iv)

Full citation text and observation details available on the Dashboard.

Other documents for Applied Therapeutics, Inc.
  • 483 - 2024-05-03May 3, 2024
  • EIR - 2024-05-03May 3, 2024
  • CRL

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Applied Therapeutics, Inc.
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.